Chengdu Kanghua Biological Products (300841) — Cash Flow Reinvestment Rate
Chengdu Kanghua Biological Products (300841) has a Cash Flow Reinvestment Rate of 0.16x as of September 2025, reinvesting CN¥14.49 Million (capex CN¥14.49 Million ) from operating cash flow of CN¥92.89 Million. Check 300841 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chengdu Kanghua Biological Products Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Chengdu Kanghua Biological Products across 10 annual periods. Explore 300841 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year capital reinvestment analysis for Chengdu Kanghua Biological Products. For live market cap and broader valuation context, see Chengdu Kanghua Biological Products stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | CN¥342.14 Million | CN¥572.24 Million | CN¥144.30 Million | ▲ +7.0% |
| 2023 | 0.56x | CN¥320.66 Million | CN¥573.98 Million | CN¥157.27 Million | ▼ -74.4% |
| 2022 | 2.18x | CN¥425.48 Million | CN¥194.99 Million | CN¥419.23 Million | ▼ -32.9% |
| 2021 | 3.25x | CN¥423.69 Million | CN¥130.33 Million | CN¥314.94 Million | ▲ +170.8% |
| 2020 | 1.20x | CN¥443.67 Million | CN¥369.56 Million | CN¥135.67 Million | ▼ -33.9% |
| 2019 | 1.82x | CN¥332.04 Million | CN¥182.73 Million | CN¥24.04 Million | ▼ -69.6% |
| 2018 | 5.97x | CN¥342.58 Million | CN¥57.35 Million | CN¥34.58 Million | ▲ +71.9% |
| 2017 | 3.47x | CN¥312.53 Million | CN¥89.96 Million | CN¥4.53 Million | ▲ +147.5% |
| 2016 | 1.40x | CN¥3.71 Million | CN¥2.64 Million | CN¥1.86 Million | ▲ +197.4% |
| 2015 | 0.47x | CN¥3.07 Million | CN¥6.51 Million | CN¥3.07 Million | — |